Kaplan Matthew L. has bought 18,000 shares of Nuvectis Pharma, Inc. [NVCT] at $0.00 a share.
Nuvectis Pharma, Inc. [NVCT] disclosed in an SEC Form 4 submission Friday, June 16, 2023 that the deal increased Kaplan Matthew L.'s holding in the company to 53,760.
Nuvectis Pharma, Inc. [NVCT] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.